Publications of Yvonne Genzel
All genres
Meeting Abstract (15)
121.
Meeting Abstract
Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, September 17, 2017 - September 21, 2017. (2017)
122.
Meeting Abstract
31 Supplement, p. S180. (2014)
The impact of MDCK cell source on the production of influenza and canine adenovirus. In New Biotechnology: Abstracts of the 16th European Congress on Biotechnology, 123.
Meeting Abstract
5 (S8 ), P129. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies
, Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells. In BMC Proceedings, 124.
Meeting Abstract
5 (S8 ), P113. 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies
, Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
Impact of different influenza cultivation conditions on HA N-glycosylation. In BMC Proceedings, 125.
Meeting Abstract
82 (9 - Special Issue : ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen), p. 1496. ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen, Aachen, Germany, September 21, 2010 - September 23, 2010. (2010)
Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von Produktionszelllinien. In Chemie Ingenieur Technik, 126.
Meeting Abstract
81 (8), p. 1241 . ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany, September 08, 2009 - September 10, 2009. Verlag Chemie, GmbH, Weinheim, Germany (2009)
Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-Bioreaktoren. In Chemie-Ingenieur-Technik, 127.
Meeting Abstract
Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture Media. In Metabolic Engineering VI: Program, p. 102. Metabolic Engineering IV, Noordwijkerhout, The Netherlands, October 01, 2006 - October 05, 2006. (2006)
Talk (93)
128.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2021, Virtual Meeting (2021)
129.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2021, Virtual Meeting (2021)
130.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2021, Virtual Meeting (2021)
131.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectiveness. ESACT Course 2021, Virtual Meeting (2021)
132.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Exercise on COVID-19 vaccines immunology and protection. ESACT Course 2021, Virtual Meeting (2021)
133.
Talk
Process intensification for virus production: stirred or shaken perfusion leads to very high titres. World Vaccine Congress Washington, Virtual Meeting (2020)
134.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (5th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2020, Virtual Meeting (2020)
135.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (5th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2020, Virtual Meeting (2020)
136.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (5th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2020, Virtual Meeting (2020)
137.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (5th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectiveness. ESACT Course 2020, Virtual Meeting (2020)
138.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (5th Edition): Exercise on COVID-19 vaccines immunology and protection. ESACT Course 2020, Virtual Meeting (2020)
139.
Talk
Evolution and selection of influenza a virus defective interfering particles in a semi-continuous production system for the use as antiviral. The seventh ESWI Influenza Conference, Virtual Meeting (2020)
140.
Talk
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Plenarsitzung der Sächischen Akademie der Wissenschaften zu Leipzig, Leipzig, Germany (2020)